Quarterly Accounts Receivable
$15.10 K
NaN%
September 30, 2024
Summary
- As of February 7, 2025, CTCX quarterly accounts receivable is $15.10 thousand
- Over the past year, CTCX quarterly accounts receivable has dropped by -$14.39 million (-99.90%).
- CTCX quarterly accounts receivable is now -99.90% below its all-time high of $14.40 million, reached on September 30, 2023.
Performance
CTCX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CTCX Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -99.9% |
3 y3 years | - | - |
5 y5 years | - | - |
CTCX Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -99.9% | at low | ||
5 y | 5-year | -99.9% | at low | ||
alltime | all time | -99.9% | at low |
Carmell Therapeutics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $15.10 K(-99.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $14.40 M |
FAQ
- What is Carmell Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly accounts receivable year-on-year change?
What is Carmell Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CTCX is $15.10 K
What is the all time high quarterly accounts receivable for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly accounts receivable is $14.40 M
What is Carmell Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CTCX quarterly accounts receivable has changed by -$14.39 M (-99.90%)